US6605712B1
(en)
*
|
1990-12-20 |
2003-08-12 |
Arch Development Corporation |
Gene transcription and ionizing radiation: methods and compositions
|
US5849719A
(en)
*
|
1993-08-26 |
1998-12-15 |
The Regents Of The University Of California |
Method for treating allergic lung disease
|
FR2711670B1
(fr)
|
1993-10-22 |
1996-01-12 |
Pasteur Institut |
Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
|
US6727230B1
(en)
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
WO1998016247A1
(en)
*
|
1996-10-11 |
1998-04-23 |
The Regents Of The University Of California |
Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
|
WO1998019709A2
(en)
*
|
1996-11-04 |
1998-05-14 |
Qiagen Gmbh |
Cationic reagents for transfection
|
PT839913E
(pt)
*
|
1996-11-04 |
2006-09-29 |
Ottawa Health Research Inst |
Metodo de expressao de polipeptidos em peixe por imerssao numa solucao de adn plasmidico
|
EP0855184A1
(en)
*
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
JP5087758B2
(ja)
*
|
1997-03-10 |
2012-12-05 |
オタワ ホスピタル リサーチ インスティチュート |
アジュバントとして非メチル化CpGジヌクレオチドを含む核酸の使用
|
US6406705B1
(en)
*
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
AU7105598A
(en)
*
|
1997-04-11 |
1998-11-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College, The |
Attenuated, invasive vaccines against fish pathogens
|
US6010705A
(en)
*
|
1997-04-11 |
2000-01-04 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Attenuated, invasive vaccines against fish pathogens
|
DE69838294T2
(de)
*
|
1997-05-20 |
2009-08-13 |
Ottawa Health Research Institute, Ottawa |
Verfahren zur Herstellung von Nukleinsäurekonstrukten
|
US20040006034A1
(en)
*
|
1998-06-05 |
2004-01-08 |
Eyal Raz |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US6589940B1
(en)
*
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US6706693B1
(en)
|
1997-08-13 |
2004-03-16 |
The Uab Research Foundation |
Vaccination by topical application of genetic vectors
|
US6348450B1
(en)
*
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US20030045492A1
(en)
*
|
1997-08-13 |
2003-03-06 |
Tang De-Chu C. |
Vaccination by topical application of recombinant vectors
|
US20030125278A1
(en)
*
|
1997-08-13 |
2003-07-03 |
Tang De-Chu C. |
Immunization of animals by topical applications of a salmonella-based vector
|
JP2002508386A
(ja)
|
1997-12-16 |
2002-03-19 |
ザ・ユニバーシティー・オブ・サスカチワン・テクノロジーズ・インコーポレーテッド |
導電性金属含有核酸
|
US6153202A
(en)
*
|
1998-03-06 |
2000-11-28 |
The United States Of America As Represented By The Secretary Of Agriculture |
In ovo methods for utilizing live Edwardsiella ictaluri against enteric septicemia in channel catfish
|
ATE356630T1
(de)
*
|
1998-04-03 |
2007-04-15 |
Univ Iowa Res Found |
Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
|
CA2328602A1
(en)
*
|
1998-05-06 |
1999-11-11 |
University Of Iowa Research Foundation |
Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
|
EP1674574A1
(en)
*
|
1998-05-14 |
2006-06-28 |
Coley Pharmaceutical GmbH |
Methods for Regulating Hematopoiesis using CpG-Oligonucleotides
|
SI1077722T1
(sl)
*
|
1998-05-22 |
2007-02-28 |
Ottawa Health Research Inst |
Metode in produkti za induciranje sluznicne imunosti
|
US6881561B1
(en)
*
|
1998-05-27 |
2005-04-19 |
Cheil Jedang Corporation |
Endonuclease of immune cell, process for producing the same and immune adjuvant using the same
|
US6562798B1
(en)
*
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US6462027B2
(en)
|
1998-07-06 |
2002-10-08 |
University Of Georgia Research Foundation, Inc. |
Delivery of nucleic acid into aquatic animals
|
US20070071776A1
(en)
*
|
1998-09-28 |
2007-03-29 |
National University Of Singapore |
Recombinant Vaccine Against Fish Infectious Diseases
|
US7160869B2
(en)
*
|
1998-12-16 |
2007-01-09 |
University Of Saskatchewan |
Biologically active metal-containing nucleic acids
|
EP1151118B1
(en)
*
|
1999-02-04 |
2008-04-09 |
The University Of Georgia Research Foundation, Inc. |
Recombinant expression of heterologous nucleic acids in protozoa
|
US7326568B2
(en)
*
|
1999-02-04 |
2008-02-05 |
University Of Georgia Research Foundation, Inc. |
Recombinant expression of heterologous nucleic acids in protozoa
|
US7026156B1
(en)
|
1999-02-04 |
2006-04-11 |
The University Of Georgia Research Foundation, Inc. |
Diagnostic and protective antigen gene sequences of ichthyophthirius
|
US6846481B1
(en)
|
1999-02-04 |
2005-01-25 |
University Of Georgia Research Foundation, Inc. |
Recombinant expression of heterologous nucleic acids in protozoa
|
US7776343B1
(en)
*
|
1999-02-17 |
2010-08-17 |
Csl Limited |
Immunogenic complexes and methods relating thereto
|
CA2299119C
(en)
*
|
1999-02-23 |
2013-02-05 |
Qiagen Gmbh |
A method of stabilizing and/or isolating nucleic acids
|
EP1177440A1
(en)
*
|
1999-04-15 |
2002-02-06 |
Genetics Institute, Inc. |
Secreted proteins and polynucleotides encoding them
|
US20040009936A1
(en)
*
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
NO311648B1
(no)
*
|
1999-05-31 |
2001-12-27 |
Genomar Asa |
DNA-sekvenser som kan benyttes til vaksine, forebyggende helsearbeid på fisk og akvatiske organismer og ellers innenbiomedisin, vektor, vaksine mot ILA-virus samt diagnostisk sett
|
EP1183010A2
(en)
*
|
1999-06-04 |
2002-03-06 |
ALZA Corporation |
Implantable gel compositions and method of manufacture
|
US6514948B1
(en)
*
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
US20040109874A1
(en)
*
|
1999-11-10 |
2004-06-10 |
Powderject Vaccines, Inc. |
Induction of mucosal immunity by vaccination via the skin route
|
EP1255849A2
(en)
*
|
2000-01-28 |
2002-11-13 |
Thomas Jefferson University |
Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
|
AU2001251407A1
(en)
*
|
2000-04-07 |
2001-10-23 |
The Regents Of The University Of California |
Synergistic improvements to polynucleotide vaccines
|
AU2001269936A1
(en)
*
|
2000-06-20 |
2002-01-02 |
Phycotransgenics, Llc |
Transgenic algae for delivering antigens to an animal
|
EP1296714B1
(en)
|
2000-06-22 |
2009-08-26 |
University Of Iowa Research Foundation |
Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer.
|
US7083858B1
(en)
|
2000-07-26 |
2006-08-01 |
Worthen Industries, Inc. |
Thermally activated adhesive films for the collation of wire staples
|
KR20020035457A
(ko)
*
|
2000-11-04 |
2002-05-11 |
정웅 |
한국형 전염성 조혈기 괴사 바이러스의 신규 지 및 엠1유전자 및 이를 이용한 어류 백신
|
AU2001297693A1
(en)
|
2000-12-08 |
2002-09-12 |
Coley Pharmaceutical Gmbh |
Cpg-like nucleic acids and methods of use thereof
|
US7906492B2
(en)
*
|
2001-01-16 |
2011-03-15 |
Sloan-Kettering Institute For Cancer Research |
Therapy-enhancing glucan
|
US8034791B2
(en)
|
2001-04-06 |
2011-10-11 |
The University Of Chicago |
Activation of Egr-1 promoter by DNA damaging chemotherapeutics
|
AU2002303247B2
(en)
*
|
2001-04-06 |
2005-03-24 |
Dana-Farber Cancer Institute |
Chemotherapeutic induction of Egr-1 promoter activity
|
US20040242523A1
(en)
*
|
2003-03-06 |
2004-12-02 |
Ana-Farber Cancer Institue And The Univiersity Of Chicago |
Chemo-inducible cancer gene therapy
|
CA2448097A1
(en)
|
2001-05-22 |
2002-11-28 |
University Of Chicago |
N4 virion single-stranded dna dependent rna polymerase
|
CA2447089A1
(en)
*
|
2001-05-24 |
2002-11-28 |
University Of Saskatchewan Technologies Inc. |
Nucleic acid circuit elements and methods
|
WO2003013597A1
(en)
*
|
2001-08-10 |
2003-02-20 |
University Of Maryland Biotechnology Institute |
Sub-unit vaccine for infectious pancreatic necrosis virus
|
DE60229422D1
(de)
|
2001-08-17 |
2008-11-27 |
Coley Pharm Gmbh |
Kombinations-motif-immunstimulierende oligonukleotide mit verbesserter wirkung
|
JP4863341B2
(ja)
*
|
2001-09-06 |
2012-01-25 |
Meiji Seikaファルマ株式会社 |
ヒラメラブドウイルス感染魚類用dnaワクチン
|
JP4360906B2
(ja)
*
|
2001-09-14 |
2009-11-11 |
サイトス バイオテクノロジー アーゲー |
ウィルス様粒子によって誘導される免疫応答を高めるための、抗原提示細胞のインビボでの活性化
|
JP4516748B2
(ja)
|
2001-09-14 |
2010-08-04 |
サイトス バイオテクノロジー アーゲー |
ウィルス様粒子中への免疫賦活物質のパッケージ化:調製法および使用法
|
CN100417419C
(zh)
*
|
2001-10-26 |
2008-09-10 |
贝勒医学院 |
改变个体的瘦体重和骨特性的组合物和方法
|
CA2472055A1
(en)
*
|
2001-11-07 |
2003-05-15 |
Inex Pharmaceuticals Corporation |
Improved mucosal vaccines and methods for using the same
|
US7241744B2
(en)
*
|
2001-12-11 |
2007-07-10 |
Baylor College Of Medicine |
Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormone
|
ATE443133T1
(de)
|
2002-02-01 |
2009-10-15 |
Life Technologies Corp |
Oligonukleotidzusammensetzungen mit verbesserter effizienz
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
US20030166282A1
(en)
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
US20030158103A1
(en)
*
|
2002-02-19 |
2003-08-21 |
Aqua Bounty Farms, Inc. |
Prevention of viral and bacterial disease in shrimp
|
US20040147467A1
(en)
*
|
2002-03-29 |
2004-07-29 |
Clouthier Sharon C. |
Nucleic acids encoding isav polypeptides
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
KR100456681B1
(ko)
*
|
2002-05-22 |
2004-11-10 |
주식회사 대웅 |
박테리아의 염색체 dna 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
|
US20040053880A1
(en)
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7576066B2
(en)
*
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
ATE497774T1
(de)
|
2002-07-15 |
2011-02-15 |
Univ Texas |
Screening kombinatorischer proteinbibliotheken mittels periplasmatischer expression
|
KR101170653B1
(ko)
|
2002-08-12 |
2012-08-03 |
제네렉스, 인코포레이티드 |
폭스바이러스 및 암과 관련된 방법 및 조성물
|
US7501128B2
(en)
*
|
2002-09-17 |
2009-03-10 |
Novartis Animal Health Us, Inc. |
IHNV G protein for immune stimulation
|
EA008777B1
(ru)
|
2002-10-29 |
2007-08-31 |
Коли Фармасьютикал Груп, Лтд. |
Способы и продукты, относящиеся к лечению и предупреждению инфекции вируса гепатита c
|
CA2502015A1
(en)
|
2002-12-11 |
2004-06-24 |
Coley Pharmaceutical Group, Inc. |
5' cpg nucleic acids and methods of use
|
TW201139672A
(en)
|
2002-12-13 |
2011-11-16 |
Novartis Ag |
Immunization of fish with plant-expressed recombinant proteins
|
IL153775A0
(en)
*
|
2003-01-01 |
2003-07-31 |
Yissum Res Dev Co |
Immunizing fish against viral infection
|
CA2517675A1
(en)
*
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
|
TW200424214A
(en)
*
|
2003-04-21 |
2004-11-16 |
Advisys Inc |
Plasmid mediated GHRH supplementation for renal failures
|
CN1798563A
(zh)
|
2003-05-15 |
2006-07-05 |
独立行政法人科学技术振兴机构 |
免疫刺激剂
|
US20070224615A1
(en)
*
|
2003-07-09 |
2007-09-27 |
Invitrogen Corporation |
Methods for assaying protein-protein interactions
|
CN1894581B
(zh)
|
2003-07-09 |
2012-02-01 |
生命技术公司 |
检测蛋白-蛋白相互作用的方法
|
GB0317733D0
(en)
|
2003-07-29 |
2003-09-03 |
Novartis Ag |
Organic compounds
|
JP4989225B2
(ja)
*
|
2003-09-25 |
2012-08-01 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
核酸親油性接合体
|
US7204993B2
(en)
*
|
2004-03-18 |
2007-04-17 |
The United States Of America As Represented By The Secretary Of Agriculture |
Streptococcus agalactiae vaccine
|
WO2005090559A1
(en)
*
|
2004-03-18 |
2005-09-29 |
Fred Hutchinson Cancer Research Center |
Methods and compositions involving s-ship promoter regions
|
TWI235440B
(en)
*
|
2004-03-31 |
2005-07-01 |
Advanced Semiconductor Eng |
Method for making leadless semiconductor package
|
US20080286294A1
(en)
*
|
2004-05-19 |
2008-11-20 |
Agence Francaise De Securite Sanitaire Des Aliment |
Nodavirus-Vlp Immunization Composition
|
WO2006017279A2
(en)
*
|
2004-07-12 |
2006-02-16 |
Board Of Regents, The University Of Texas System |
Methods and compositions related to identifying protein-protein interactions
|
KR100958505B1
(ko)
|
2004-07-18 |
2010-05-17 |
씨에스엘 리미티드 |
면역자극 복합체 및 향상된 인터페론-감마 반응을 유도하기위한 올리고뉴클레오티드 제제
|
US7334538B1
(en)
*
|
2004-07-27 |
2008-02-26 |
Aquascience Research Group, Inc. |
Topical medicants for aquatic animals
|
ES2247942B1
(es)
*
|
2004-08-27 |
2006-10-01 |
Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria (Inia) |
Construccion genica, vector y vacuna adn para la vacunacion de animales acuaticos.
|
EP2281888B1
(en)
|
2004-11-12 |
2015-01-07 |
Asuragen, Inc. |
Methods and compositions involving miRNA and miRNA inhibitor molecules
|
KR100701672B1
(ko)
*
|
2004-12-10 |
2007-04-03 |
대한민국 |
한국형 돌돔 이리도바이러스의 유전자 및 이를 이용한 백신
|
JP2008531581A
(ja)
*
|
2005-02-23 |
2008-08-14 |
ユーエービー リサーチ ファウンデーション |
アルキル−グリコシドで増強されたワクチン接種
|
AU2006269555A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Coley Pharmaceutical Group, Inc. |
Anti-CTLA-4 antibody and CpG-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
EP1933857A2
(en)
*
|
2005-09-07 |
2008-06-25 |
Jennerex Biotherapeutics ULC |
Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
|
CN100370023C
(zh)
*
|
2005-11-17 |
2008-02-20 |
中国海洋大学 |
利用大菱鲆鳍细胞系繁殖大菱鲆出血性败血症病毒的方法
|
EP1975238A4
(en)
*
|
2006-01-11 |
2009-11-18 |
Inst Nac Investigacion Inia |
GENETIC CONSTRUCTION, VECTOR AND DNA VACCINE FOR AQUATIC ANIMAL VACCINATION
|
US20090053221A1
(en)
*
|
2006-01-17 |
2009-02-26 |
Cheung Nai-Kong V |
Immune response enhancing glucan
|
US8323644B2
(en)
|
2006-01-17 |
2012-12-04 |
Sloan-Kettering Institute For Cancer Research |
Therapy-enhancing glucan
|
EP1998800A2
(en)
|
2006-01-18 |
2008-12-10 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
JP5239023B2
(ja)
|
2006-04-13 |
2013-07-17 |
国立大学法人東京海洋大学 |
コイヘルペスウイルス(khv)病用dnaワクチン
|
EP2069791B1
(en)
|
2006-07-27 |
2012-01-25 |
University of Maryland, Baltimore |
Cellular receptor for antiproliferative factor
|
CN105769931B
(zh)
*
|
2006-09-15 |
2021-04-27 |
渥太华医院研究机构 |
溶瘤弹状病毒
|
US8753840B2
(en)
*
|
2006-10-20 |
2014-06-17 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Modified cyanobacteria
|
US8067179B2
(en)
|
2006-11-30 |
2011-11-29 |
Research Development Foundation |
Immunoglobulin libraries
|
EP2113511A4
(en)
*
|
2006-12-22 |
2010-09-15 |
Soluciones Biotecnologicas Inn |
DNA VACCINES FOR FISH
|
KR20080084528A
(ko)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
EP2155789B1
(en)
|
2007-05-01 |
2013-07-24 |
Research Development Foundation |
Immunoglobulin fc libraries
|
US20100317084A1
(en)
*
|
2007-05-10 |
2010-12-16 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacteria comprising vectors for expression of nucleic acid sequences encoding antigens
|
WO2009025888A2
(en)
|
2007-05-10 |
2009-02-26 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety
|
CA2697538C
(en)
|
2007-08-31 |
2019-02-12 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
GB0717911D0
(en)
|
2007-09-14 |
2007-10-24 |
Univ Stirling |
Vaccine
|
WO2009046451A1
(en)
|
2007-10-05 |
2009-04-09 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium capable of eliciting a protective immune response against c. perfringens
|
CA2711499C
(en)
|
2008-01-10 |
2018-09-25 |
Research Development Foundation |
Vaccines and diagnostics for the ehrlichioses
|
CN102066937A
(zh)
|
2008-01-25 |
2011-05-18 |
P53股份有限公司 |
P53生物标记物
|
AU2009225665B9
(en)
|
2008-03-17 |
2015-01-15 |
The Scripps Research Institute |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
GB0808780D0
(en)
*
|
2008-05-15 |
2008-06-18 |
Big Dna Ltd |
Fish vaccines
|
DK2297307T3
(en)
|
2008-06-04 |
2016-07-25 |
Cellular Dynamics Int Inc |
PROCEDURES FOR THE MANUFACTURE OF IPS CELLS USING NON-VIRAL METHODS
|
CA2734128A1
(en)
|
2008-08-12 |
2010-02-18 |
Cellular Dynamics International, Inc. |
Methods for the production of ips cells
|
AU2009282625A1
(en)
|
2008-08-18 |
2010-02-25 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Derivatives of APF and methods of use
|
EP2341929B1
(en)
|
2008-10-06 |
2017-01-25 |
University Of Chicago |
Compositions and methods related to bacterial emp proteins
|
WO2010045620A1
(en)
|
2008-10-17 |
2010-04-22 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
|
JP5651125B2
(ja)
|
2008-12-10 |
2015-01-07 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Mek阻害剤に対する耐性を付与するmek突然変異
|
EP3312269A1
(en)
|
2008-12-17 |
2018-04-25 |
The Scripps Research Institute |
Generation and maintenance of stem cells
|
US8492133B2
(en)
|
2009-01-20 |
2013-07-23 |
Ramot At Tel Aviv University, Ltd. |
MIR-21 promoter driven targeted cancer therapy
|
US20100183523A1
(en)
|
2009-01-22 |
2010-07-22 |
Wagner Richard E |
Dental composition and method
|
WO2011005341A2
(en)
|
2009-04-03 |
2011-01-13 |
University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
US9163219B2
(en)
*
|
2009-04-14 |
2015-10-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Single expression vector for generation of a virus with a segmented genome
|
DK3061766T3
(da)
|
2009-04-28 |
2020-03-16 |
Univ Vanderbilt |
Sammensætninger og fremgangsmåder til behandlingen af sygdomme der involverer epitelcelleapoptose
|
WO2010135563A1
(en)
|
2009-05-22 |
2010-11-25 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium and methods of antigen and nucleic acid delivery
|
US9045742B2
(en)
*
|
2009-05-29 |
2015-06-02 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant Edwardsiella bacterium
|
CA2764373C
(en)
|
2009-06-05 |
2019-11-19 |
Cellular Dynamics International, Inc. |
Reprogramming t cells and hematophietic cells
|
CA2772298A1
(en)
|
2009-08-26 |
2011-03-03 |
Research Development Foundation |
Methods for creating antibody libraries
|
ES2671570T3
(es)
|
2009-09-14 |
2018-06-07 |
Sillajen Biotherapeutics, Inc. |
Terapia combinada contra el cáncer con virus oncolítico de vaccinia
|
WO2011045573A2
(en)
|
2009-10-15 |
2011-04-21 |
University Court Of The University Of Edinburgh |
Staphylococcal antigens
|
EP3235901B1
(en)
|
2009-10-16 |
2022-12-21 |
The Scripps Research Institute |
Induction of pluripotent cells
|
MX337062B
(es)
|
2009-12-10 |
2016-02-11 |
Ottawa Hospital Res Inst |
Rabdovirus oncolítico.
|
US9062297B2
(en)
|
2010-01-13 |
2015-06-23 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Yersinia pestis vaccine
|
US8889121B2
(en)
|
2010-01-22 |
2014-11-18 |
The Arizona Board Of Regents For An On Behalf Of Arizona State University |
Bacterium comprising a regulated rfaH nucleic acid
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
RU2571930C2
(ru)
|
2010-02-25 |
2015-12-27 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Мутации braf, обеспечивающие резистентность к ингибиторам braf
|
EP3214174B1
(en)
|
2010-03-04 |
2019-10-16 |
InteRNA Technologies B.V. |
A mirna molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with emt
|
JP5909482B2
(ja)
|
2010-03-31 |
2016-04-26 |
ザ スクリプス リサーチ インスティテュート |
細胞の再プログラム
|
EP2555794A4
(en)
|
2010-04-05 |
2014-01-15 |
Univ Chicago |
PROTEIN A (SPA) ANTIBODY COMPOSITIONS AND METHODS AS AN IMMUNE RESPONSE AMPLIFIER
|
US9249195B2
(en)
|
2010-04-07 |
2016-02-02 |
Vanderbilt University |
Reovirus vaccines and methods of use therefor
|
DK2560672T3
(en)
|
2010-04-19 |
2014-03-17 |
Res Dev Foundation |
RTEF-1 variants and their uses
|
US9598697B2
(en)
|
2010-05-28 |
2017-03-21 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium to decrease tumor growth
|
CN103097526B
(zh)
|
2010-06-09 |
2015-09-16 |
达纳-法伯癌症研究所公司 |
赋予针对raf和mek抑制剂的抗性的mek1突变
|
EP2580320B1
(en)
|
2010-06-14 |
2018-08-01 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
US20110312001A1
(en)
|
2010-06-15 |
2011-12-22 |
Emile Nuwaysir |
Compendium of ready-built stem cell models for interrogation of biological response
|
CA2802249A1
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
AU2011274367B2
(en)
|
2010-07-02 |
2015-04-23 |
The University Of Chicago |
Compositions and methods related to protein A (SpA) variants
|
AU2011274619B2
(en)
|
2010-07-06 |
2016-11-10 |
Interna Technologies Bv |
miRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
|
EP2591093B1
(en)
|
2010-07-07 |
2018-11-28 |
FUJIFILM Cellular Dynamics, Inc. |
Endothelial cell production by programming
|
CA2806858C
(en)
|
2010-08-04 |
2021-06-15 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized b cells
|
EP2614074A1
(en)
|
2010-09-09 |
2013-07-17 |
The University of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
FR2964569B1
(fr)
|
2010-09-10 |
2012-10-19 |
Ct De Cooperation Internationale En Rech Agronomique Pour Le Dev Cirad |
Nouveaux liposomes de vaccination genique
|
EP3536337A1
(en)
|
2010-09-22 |
2019-09-11 |
The Regents of the University of Colorado, a body corporate |
Therapeutic applications of smad7
|
US20130267029A1
(en)
|
2010-10-01 |
2013-10-10 |
Fundacion Centro Nacional de Ivestigaciones Oncologicas, Carlos |
Manipulation of stem cell function by p53 isoforms
|
AU2011349446C1
(en)
|
2010-12-22 |
2016-01-21 |
Fate Therapauetics, Inc. |
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
|
KR101942237B1
(ko)
|
2011-01-04 |
2019-01-25 |
신라젠(주) |
종양 항원에 대한 항체의 생산 및 종양용해 우두 바이러스의 투여에 의한 종양 특이적 보체 의존적 세포독성의 생산
|
EP2474617A1
(en)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
Mir for treating neo-angiogenesis
|
WO2012109133A1
(en)
|
2011-02-07 |
2012-08-16 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
WO2012109208A2
(en)
|
2011-02-08 |
2012-08-16 |
Cellular Dynamics International, Inc. |
Hematopoietic precursor cell production by programming
|
WO2012136653A1
(en)
|
2011-04-08 |
2012-10-11 |
Novvac Aps |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
ES2931180T3
(es)
|
2011-05-19 |
2022-12-27 |
Fund Publica Andaluza Progreso Y Salud |
Sistema de tipo Tet-on lentivírico de promotor dual muy inducible
|
US9364532B2
(en)
|
2011-06-08 |
2016-06-14 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Compositions and methods for glioblastoma treatment
|
JP2014520551A
(ja)
|
2011-07-11 |
2014-08-25 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
細胞のリプログラミング方法およびゲノムの改変方法
|
CN103906535B
(zh)
|
2011-08-15 |
2017-07-14 |
芝加哥大学 |
与葡萄球菌蛋白a的抗体相关的组合物和方法
|
WO2013026015A1
(en)
|
2011-08-18 |
2013-02-21 |
Dana-Farber Cancer Institute, Inc. |
Muc1 ligand traps for use in treating cancers
|
EP2753686A4
(en)
*
|
2011-09-09 |
2015-06-03 |
Advanced Bionutrition Corp |
BIVALENT IPNV ISAV VACCINE USING A VIRUS LIKE PARTICLE PLATFORM AND USE METHOD THEREFOR
|
WO2013053899A1
(en)
|
2011-10-12 |
2013-04-18 |
Moeller Niels Iversen |
Peptides derived from campylobacter jejuni and their use in vaccination
|
WO2013086514A1
(en)
|
2011-12-08 |
2013-06-13 |
Pentair Water Pool And Spa, Inc. |
Aquaculture pump system and method
|
ES2688619T3
(es)
|
2011-12-22 |
2018-11-05 |
Interna Technologies B.V. |
MiARN para tratar el cáncer de cabeza y de cuello
|
WO2013144579A1
(en)
|
2012-03-30 |
2013-10-03 |
Heriot-Watt University |
Use of flagellin as a vaccine
|
JP6251730B2
(ja)
|
2012-04-26 |
2017-12-20 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
黄色ブドウ球菌(staphylococcusaureus)疾患の間にコアグラーゼ活性を中和する抗体に関連した組成物および方法
|
JP6670106B2
(ja)
|
2012-04-26 |
2020-03-18 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
ブドウ球菌コアグラーゼ抗原およびその使用方法
|
US9303264B2
(en)
|
2012-05-18 |
2016-04-05 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Photosynthetic microorganisms expressing thermostable lipase
|
WO2014008475A2
(en)
|
2012-07-05 |
2014-01-09 |
The Ohio State University |
Compositions and methods related to viral vaccines
|
EP2893937B1
(en)
*
|
2012-09-10 |
2020-07-01 |
National University Corporation Tokyo University of Marine Science And Technology |
Dna vaccine against pseudotuberculosis in marine fish
|
WO2014046410A1
(ko)
*
|
2012-09-20 |
2014-03-27 |
중앙대학교 산학협력단 |
노다바이러스의 바이러스 유사입자의 생산방법, 이를 발현하는 효모 세포주 및 이를 포함하는 백신 조성물
|
EP2912058A1
(en)
|
2012-10-23 |
2015-09-02 |
The Board of Regents of The University of Texas System |
Antibodies with engineered igg fc domains
|
WO2014072357A1
(en)
|
2012-11-06 |
2014-05-15 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated b-raf pathway
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
ES2904803T3
(es)
|
2013-02-20 |
2022-04-06 |
Regeneron Pharma |
Modificación genética de ratas
|
AU2014221143B2
(en)
|
2013-02-21 |
2019-02-07 |
Turnstone Limited Partnership |
Vaccine composition
|
WO2014130770A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
WO2014134144A1
(en)
|
2013-02-28 |
2014-09-04 |
The General Hospital Corporation |
Mirna profiling compositions and methods of use
|
WO2014132137A2
(en)
|
2013-03-01 |
2014-09-04 |
Université De Genève |
Transgenic cell selection
|
WO2014138670A1
(en)
|
2013-03-08 |
2014-09-12 |
The Regents Of The University Of Colorado, A Body Corporate |
Ptd-smad7 therapeutics
|
EP2969158A4
(en)
|
2013-03-14 |
2016-12-21 |
Pentair Water Pool & Spa Inc |
CARBON DIOXIDE CONTROL SYSTEM FOR AN AQUACULTURE
|
WO2014145661A1
(en)
|
2013-03-15 |
2014-09-18 |
Pentair Water Pool And Spa, Inc. |
Dissolved oxygen control system for aquaculture
|
US9580718B2
(en)
|
2013-06-17 |
2017-02-28 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Attenuated live bacteria with increased acid resistance and methods of use thereof
|
US10894963B2
(en)
|
2013-07-25 |
2021-01-19 |
Exicure, Inc. |
Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
|
WO2015035395A1
(en)
|
2013-09-09 |
2015-03-12 |
Figene, Llc |
Gene therapy for the regeneration of chondrocytes or cartilage type cells
|
CA2929555A1
(en)
|
2013-11-08 |
2015-05-14 |
Baylor Research Institute |
Nuclear localization of glp-1 stimulates myocardial regeneration and reverses heart failure
|
EP3065775B1
(en)
|
2013-11-08 |
2020-09-30 |
The Board of Regents of the University of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
JP6669650B2
(ja)
*
|
2013-11-15 |
2020-03-18 |
ユニバーシティ オブ メリーランド,ボルチモア カウンティ |
生殖能力のない魚及び卵生水生動物を作出する方法、ならびに卵及び胚内に化合物を送達する方法
|
US20160368952A1
(en)
|
2013-12-03 |
2016-12-22 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
CA2938111C
(en)
|
2014-01-29 |
2024-02-06 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against the muc1-c/extracellular domain (muc1-c/ecd)
|
EP3105332A4
(en)
|
2014-02-14 |
2018-01-10 |
University of Utah Research Foundation |
Methods and compositions for inhibiting retinopathy of prematurity
|
EP3110836A1
(en)
|
2014-02-25 |
2017-01-04 |
Research Development Foundation |
Sty peptides for inhibition of angiogenesis
|
EP3805369A1
(en)
|
2014-03-04 |
2021-04-14 |
Fate Therapeutics, Inc. |
Improved reprogramming methods and cell culture platforms
|
US20170107486A1
(en)
|
2014-04-21 |
2017-04-20 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
US10434064B2
(en)
|
2014-06-04 |
2019-10-08 |
Exicure, Inc. |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
WO2016025510A1
(en)
|
2014-08-12 |
2016-02-18 |
Rappolee Daniel A |
Systems and methods to detect stem cell stress and uses thereof
|
EP3218002B1
(en)
|
2014-11-13 |
2020-08-19 |
Evaxion Biotech ApS |
Peptides derived from acinetobacter baumannii and their use in vaccination
|
EP3220895B1
(en)
|
2014-11-21 |
2022-08-31 |
Northwestern University |
The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
EP3244918A2
(en)
|
2015-01-12 |
2017-11-22 |
Evaxion Biotech ApS |
Proteins and nucleic acids useful in vaccines targeting klebsiella pneumoniae
|
WO2016120697A1
(en)
|
2015-01-28 |
2016-08-04 |
Sabic Global Technologies B.V. |
Methods and compositions for high-efficiency production of biofuel and/or biomass
|
WO2016130516A1
(en)
|
2015-02-09 |
2016-08-18 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides displaying improved complement activation
|
WO2016134293A1
(en)
|
2015-02-20 |
2016-08-25 |
Baylor College Of Medicine |
p63 INACTIVATION FOR THE TREATMENT OF HEART FAILURE
|
WO2016196366A1
(en)
|
2015-05-29 |
2016-12-08 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Extension of replicative lifespan in diseases of premature aging using p53 isoforms
|
US20180201656A1
(en)
|
2015-07-04 |
2018-07-19 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting Pseudomonas Aeruginosa
|
CA2994039A1
(en)
*
|
2015-07-31 |
2017-02-09 |
Bayer Animal Health Gmbh |
Enhanced immune response in aquatic species
|
WO2017040380A2
(en)
|
2015-08-28 |
2017-03-09 |
Research Development Foundation |
Engineered antibody fc variants
|
AU2016338680B2
(en)
|
2015-10-16 |
2022-11-17 |
Fate Therapeutics, Inc. |
Platform for the induction and maintenance of ground state pluripotency
|
AU2016342183B2
(en)
|
2015-10-20 |
2022-03-03 |
FUJIFILM Cellular Dynamics, Inc. |
Methods for directed differentiation of pluripotent stem cells to immune cells
|
CN108463548B
(zh)
|
2015-10-30 |
2023-04-18 |
加利福尼亚大学董事会 |
由干细胞产生t细胞的方法及使用所述t细胞的免疫治疗方法
|
WO2017079202A1
(en)
|
2015-11-02 |
2017-05-11 |
Board Of Regents, The University Of Texas System |
Methods of cd40 activation and immune checkpoint blockade
|
CA3004530A1
(en)
|
2015-11-07 |
2017-05-11 |
Multivir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
|
DK3373968T3
(da)
|
2015-11-09 |
2024-05-13 |
Childrens Hospital Philadelphia |
Glypican 2 som en tumormarkør og terapeutisk mål
|
BR112018009538B1
(pt)
|
2015-11-13 |
2023-02-14 |
Applied Lifesciences and Systems, LLC |
Sistemas para entrega de uma substância ao olho de um animal
|
WO2017134441A1
(en)
*
|
2016-02-02 |
2017-08-10 |
Benchmark Animal Health Limited |
Methods of producing viruses
|
WO2017144523A1
(en)
|
2016-02-22 |
2017-08-31 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
WO2017168348A1
(en)
|
2016-03-31 |
2017-10-05 |
Baylor Research Institute |
Angiopoietin-like protein 8 (angptl8)
|
WO2017216384A1
(en)
|
2016-06-17 |
2017-12-21 |
Evaxion Biotech Aps |
Vaccination targeting ichthyophthirius multifiliis
|
WO2017220787A1
(en)
|
2016-06-24 |
2017-12-28 |
Evaxion Biotech Aps |
Vaccines against aearomonas salmonicida infection
|
AU2017290805B2
(en)
|
2016-07-01 |
2023-11-16 |
Research Development Foundation |
Elimination of proliferating cells from stem cell-derived grafts
|
WO2018015575A1
(en)
|
2016-07-22 |
2018-01-25 |
Evaxion Biotech Aps |
Chimeric proteins for inducing immunity towards infection with s. aureus
|
US9963498B2
(en)
|
2016-08-18 |
2018-05-08 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of VLA-4 and IGF-1R
|
US11364304B2
(en)
|
2016-08-25 |
2022-06-21 |
Northwestern University |
Crosslinked micellar spherical nucleic acids
|
AU2017319702A1
(en)
|
2016-09-02 |
2019-04-11 |
The Regents Of The University Of California |
Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments
|
US10961505B2
(en)
|
2016-10-05 |
2021-03-30 |
FUJIFILM Cellular Dynamics, Inc. |
Generating mature lineages from induced pluripotent stem cells with MECP2 disruption
|
BR112019006910A2
(pt)
|
2016-10-05 |
2019-07-02 |
Fujifilm Cellular Dynamics Inc |
métodos para diferenciação dirigida de células-tronco pluripotentes para células imunes homozigóticas de hla
|
EP3551226A1
(en)
|
2016-12-12 |
2019-10-16 |
MultiVir Inc. |
Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases
|
US11718648B2
(en)
|
2017-01-05 |
2023-08-08 |
Evaxion Biotech A/S |
Vaccines targeting Pseudomonas aeruginosa
|
AU2018254442B2
(en)
|
2017-04-18 |
2024-03-28 |
FUJIFILM Cellular Dynamics, Inc. |
Antigen-specific immune effector cells
|
CN107099496B
(zh)
*
|
2017-04-25 |
2021-04-13 |
中国农业科学院哈尔滨兽医研究所 |
融合表达鸡传染性法氏囊病毒vp2蛋白和沙门菌属外膜蛋白的重组乳酸菌菌株及其用途
|
WO2018201090A1
(en)
|
2017-04-28 |
2018-11-01 |
Exicure, Inc. |
Synthesis of spherical nucleic acids using lipophilic moieties
|
CN111566212A
(zh)
|
2017-11-03 |
2020-08-21 |
因特尔纳技术有限公司 |
miRNA分子,等同物,安塔够妙或其来源用于治疗和/或诊断与神经元缺陷相关的病症和/或疾病或用于神经元生成和/或再生
|
WO2019099493A1
(en)
|
2017-11-14 |
2019-05-23 |
Henry Ford Health System |
Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury
|
EP3720486A1
(en)
|
2017-12-06 |
2020-10-14 |
Intervet International B.V. |
Use of a non-structural protein from prv to protect against heart and skeletal muscle inflammation
|
CN112313339A
(zh)
|
2018-01-05 |
2021-02-02 |
渥太华医院研究所 |
修饰的牛痘载体
|
WO2019145399A1
(en)
|
2018-01-24 |
2019-08-01 |
Evaxion Biotech Aps |
Vaccines for prophylaxis of s. aureus infections
|
KR20200135986A
(ko)
|
2018-03-19 |
2020-12-04 |
멀티비르 인코포레이티드 |
종양 억제인자 유전자 치료 및 cd122/cd132 작용제를 포함하는 암 치료를 위한 방법 및 조성물
|
WO2019186274A2
(en)
|
2018-03-30 |
2019-10-03 |
University Of Geneva |
Micro rna expression constructs and uses thereof
|
RU2702716C2
(ru)
*
|
2018-04-03 |
2019-10-09 |
Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) |
Рекомбинантная плазмида pHis6-flagG-protE, обеспечивающая синтез рекомбинантного химерного белка, включающего эпитопы гликопротеина Е вируса клещевого энцефалита и флагеллин G S.typhii и используемого в качестве основы для вакцины против вируса клещевого энцефалита
|
CN113164556A
(zh)
|
2018-08-30 |
2021-07-23 |
特纳亚治疗股份有限公司 |
用心肌蛋白和ascl1进行的心脏细胞重编程
|
WO2020069313A2
(en)
|
2018-09-28 |
2020-04-02 |
Henry Ford Health System |
Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat stroke
|
US20220111031A1
(en)
|
2018-10-22 |
2022-04-14 |
Evaxion Biotech Aps |
Vaccines targeting M. catharrhalis
|
WO2020171889A1
(en)
|
2019-02-19 |
2020-08-27 |
University Of Rochester |
Blocking lipid accumulation or inflammation in thyroid eye disease
|
EP3931206A1
(en)
|
2019-02-27 |
2022-01-05 |
Evaxion Biotech ApS |
Vaccines targeting h. influenzae
|
US20230137971A1
(en)
|
2019-07-11 |
2023-05-04 |
Tenaya Therapeutics Inc. |
Cardiac cell reprogramming with micrornas and other factors
|
EP3999546A1
(en)
|
2019-07-19 |
2022-05-25 |
The Children's Hospital of Philadelphia |
Chimeric antigen receptors containing glypican 2 binding domains
|
CN115175680A
(zh)
|
2019-10-18 |
2022-10-11 |
加利福尼亚大学董事会 |
Plxdc激活剂及其用于治疗血管病症的用途
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
WO2021140123A1
(en)
|
2020-01-06 |
2021-07-15 |
Evaxion Biotech Aps |
Vaccines targeting neisseria gonorrhoeae
|
CA3173567A1
(en)
|
2020-03-02 |
2021-09-10 |
Tenaya Therapeutics, Inc. |
Gene vector control by cardiomyocyte-expressed micrornas
|
EP4127148A1
(en)
|
2020-03-25 |
2023-02-08 |
Erasmus University Rotterdam Medical Center |
Reporter system for radionuclide imaging
|
JP2023537558A
(ja)
|
2020-05-27 |
2023-09-04 |
アンチオン バイオサイエンシーズ エスアー |
目的の抗原にcar t細胞をリダイレクトするためのアダプター分子
|
WO2021243203A1
(en)
|
2020-05-29 |
2021-12-02 |
FUJIFILM Cellular Dynamics, Inc. |
Bilayer of retinal pigmented epithelium and photoreceptors and use thereof
|
CN116033912A
(zh)
|
2020-05-29 |
2023-04-28 |
富士胶片细胞动力公司 |
视网膜色素上皮和感光器双细胞聚集物及其使用方法
|
WO2022053130A1
(en)
|
2020-09-09 |
2022-03-17 |
Sid Alex Group, S.R.O. |
Antago-mir-155 for treatment of v-src, c-src-tyrosine kinase-induced cancers
|
WO2022173767A1
(en)
|
2021-02-09 |
2022-08-18 |
University Of Houston System |
Oncolytic virus for systemic delivery and enhanced anti-tumor activities
|
US20240122865A1
(en)
|
2021-02-19 |
2024-04-18 |
Pfizer Inc. |
Methods of Protecting RNA
|
CN117242173A
(zh)
|
2021-05-03 |
2023-12-15 |
安斯泰来再生医药协会 |
产生成熟角膜内皮细胞的方法
|
BR112023022181A2
(pt)
|
2021-05-07 |
2024-02-06 |
Astellas Inst For Regenerative Medicine |
Métodos de geração de hepatócitos maduros
|
EP4347796A1
(en)
|
2021-05-26 |
2024-04-10 |
Fujifilm Cellular Dynamics, Inc. |
Methods to prevent rapid silencing of genes in pluripotent stem cells
|
CA3224564A1
(en)
|
2021-07-05 |
2023-01-12 |
Andreas Holm MATTSSON |
Vaccines targeting neisseria gonorrhoeae
|
WO2023089556A1
(en)
|
2021-11-22 |
2023-05-25 |
Pfizer Inc. |
Reducing risk of antigen mimicry in immunogenic medicaments
|
WO2023144779A1
(en)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Coronavirus antigen variants
|
WO2023178191A1
(en)
|
2022-03-16 |
2023-09-21 |
University Of Houston System |
Persistent hsv gene delivery system
|
GB202205265D0
(en)
|
2022-04-11 |
2022-05-25 |
Mogrify Ltd |
Cell conversion
|
WO2023213393A1
(en)
|
2022-05-04 |
2023-11-09 |
Evaxion Biotech A/S |
Staphylococcal protein variants and truncates
|
GB202206507D0
(en)
|
2022-05-04 |
2022-06-15 |
Antion Biosciences Sa |
Expression construct
|
WO2023239940A1
(en)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
WO2024006911A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Holdings America Corporation |
Ipsc-derived astrocytes and methods of use thereof
|